Biomoda Partners With Christiana for Pilot Study on Cancer Diagnostic

Cancer diagnostics company Biomoda, Inc. Thursday announced that The Helen F. Graham Cancer Center associated with Christiana Care Health System, a screening site for the International Early Lung Cancer Program, will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath assay, an early-stage diagnostic test for lung cancer.
Earth Times